Year |
Citation |
Score |
2020 |
Krishnan V, Tallapragada S, Schaar B, Kamat K, Chanana AM, Zhang Y, Patel S, Parkash V, Rinker-Schaeffer C, Folkins AK, Rankin EB, Dorigo O. Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Communications Biology. 3: 524. PMID 32963283 DOI: 10.1038/s42003-020-01246-z |
0.356 |
|
2019 |
Krishnan V, Tallapragada S, Schaar B, Chanana A, Rinker-Schaeffer C, Dorigo O. Abstract TMIM-076: OMENTAL MACROPHAGES REGULATE OVARIAN CANCER METASTATIC COLONIZATION THROUGH THE CCL6-CCR1 SIGNALING AXIS Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Tmim-076 |
0.498 |
|
2017 |
Krishnan V, Schaar B, Rinker-Schaeffer C, Dorigo O. Abstract TMEM-028: OMENTAL MACROPHAGES REGULATE OVARIAN CANCER METASTATIC COLONIZATION Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Tmem-028 |
0.477 |
|
2016 |
Krishnan V, Mitchell K, Miska J, George S, Shaw P, Seewaldt V, Lesniak M, Chekmareva M, Becker L, Parkash V, Miranti C, Rinker-Schaeffer C. Abstract A82: Ovarian cancer cells hijack immune functions of omental milky spots for metastatic colonization. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A82 |
0.497 |
|
2016 |
Krishnan V, Rinker-Schaeffer C, Dorigo O. Omental macrophages: Drivers of ovarian cancer metastatic colonization Gynecologic Oncology. 141: 68. DOI: 10.1016/J.Ygyno.2016.04.197 |
0.425 |
|
2015 |
Krishnan V, Clark R, Chekmareva M, Johnson A, George S, Shaw P, Seewaldt V, Rinker-Schaeffer C. In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose. Journal of Visualized Experiments : Jove. PMID 26555178 DOI: 10.3791/52721 |
0.491 |
|
2014 |
Li G, Ci W, Karmakar S, Chen K, Dhar R, Fan Z, Guo Z, Zhang J, Ke Y, Wang L, Zhuang M, Hu S, Li X, Zhou L, Li X, ... ... Rinker-Schaeffer C, et al. SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer. Cancer Cell. 25: 455-68. PMID 24656772 DOI: 10.1016/J.Ccr.2014.02.007 |
0.418 |
|
2013 |
Clark R, Krishnan V, Schoof M, Rodriguez I, Theriault B, Chekmareva M, Rinker-Schaeffer C. Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. The American Journal of Pathology. 183: 576-91. PMID 23885715 DOI: 10.1016/J.Ajpath.2013.04.023 |
0.495 |
|
2013 |
Souris JS, Hickson JA, Msezane L, Rinker-Schaeffer CW, Chen CT. Flexible peritoneal windows for quantitative fluorescence and bioluminescence preclinical imaging Molecular Imaging. 12: 28-38. PMID 23348789 DOI: 10.2310/7290.2012.00017 |
0.677 |
|
2013 |
Howe EN, Krishnan V, Otto K, Szmulewitz RZ, Rinker-Schaeffer C. Abstract B95: Examining reciprocal temporal interactions between human prostate cancer cells and the bone microenvironment Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B95 |
0.463 |
|
2013 |
Clark R, Krishnan V, Schoof M, Rodriguez I, Chekmareva M, Theriault B, Rinker-Schaeffer C. Abstract B65: Milky spots are required for ovarian cancer metastatic colonization of peritoneal adipose depots Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B65 |
0.495 |
|
2013 |
Krishnan V, Clark R, Rinker-Schaeffer C. Abstract 4853: Omental milky-spots serve as a niche for ovarian cancer metastatic colonization Cancer Research. 74: 4853-4853. DOI: 10.1158/1538-7445.Am2014-4853 |
0.507 |
|
2012 |
Krishnan V, Stadick N, Clark R, Bainer R, Veneris JT, Khan S, Drew A, Rinker-Schaeffer C. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization. Cancer Metastasis Reviews. 31: 605-13. PMID 22706843 DOI: 10.1007/S10555-012-9371-Y |
0.557 |
|
2012 |
Bainer RO, Veneris JT, Yamada SD, Montag A, Lingen MW, Gilad Y, Rinker-Schaeffer CW. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clinical & Experimental Metastasis. 29: 397-408. PMID 22350525 DOI: 10.1007/S10585-011-9448-Y |
0.412 |
|
2012 |
Szmulewitz RZ, Clark R, Lotan T, Otto K, Taylor Veneris J, Macleod K, Rinker-Schaeffer C. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression. International Journal of Cancer. 130: 509-20. PMID 21351092 DOI: 10.1002/Ijc.26005 |
0.5 |
|
2011 |
Knopeke MT, Ritschdorff ET, Clark R, Vander Griend DJ, Khan S, Thobe M, Shear JB, Rinker-Schaeffer CW. Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. Febs Letters. 585: 3159-65. PMID 21925502 DOI: 10.1016/J.Febslet.2011.09.007 |
0.748 |
|
2011 |
Thiolloy S, Rinker-Schaeffer CW. Thinking outside the box: using metastasis suppressors as molecular tools. Seminars in Cancer Biology. 21: 89-98. PMID 21147228 DOI: 10.1016/j.semcancer.2010.12.008 |
0.375 |
|
2010 |
Khan S, Taylor JL, Rinker-Schaeffer CW. Disrupting ovarian cancer metastatic colonization: insights from metastasis suppressor studies. Journal of Oncology. 2010: 286925. PMID 20300552 DOI: 10.1155/2010/286925 |
0.426 |
|
2010 |
Khan SM, Funk HM, Thiolloy S, Lotan TL, Hickson J, Prins GS, Drew AF, Rinker-Schaeffer CW. In vitro metastatic colonization of human ovarian cancer cells to the omentum Clinical and Experimental Metastasis. 27: 185-196. PMID 20229256 DOI: 10.1007/S10585-010-9317-0 |
0.753 |
|
2009 |
Posadas EM, Al-Ahmadie H, Robinson VL, Jagadeeswaran R, Otto K, Kasza KE, Tretiakov M, Siddiqui J, Pienta KJ, Stadler WM, Rinker-Schaeffer C, Salgia R. FYN is overexpressed in human prostate cancer. Bju International. 103: 171-7. PMID 18990162 DOI: 10.1111/J.1464-410X.2008.08009.X |
0.436 |
|
2009 |
Hickson J, Diane Yamada S, Berger J, Alverdy J, O'Keefe J, Bassler B, Rinker-Schaeffer C. Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis. Clinical & Experimental Metastasis. 26: 67-76. PMID 18516689 DOI: 10.1007/S10585-008-9177-Z |
0.753 |
|
2008 |
Taylor JL, Szmulewitz RZ, Lotan T, Hickson J, Griend DV, Yamada SD, Macleod K, Rinker-Schaeffer CW. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells. Cancer Letters. 272: 12-22. PMID 18572308 DOI: 10.1016/J.Canlet.2008.05.012 |
0.783 |
|
2008 |
Lotan T, Hickson J, Souris J, Huo D, Taylor J, Li T, Otto K, Yamada SD, Macleod K, Rinker-Schaeffer CW. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation. Cancer Research. 68: 2166-75. PMID 18381422 DOI: 10.1158/0008-5472.Can-07-1568 |
0.782 |
|
2008 |
Robinson VL, Shalhav O, Otto K, Kawai T, Gorospe M, Rinker-Schaeffer CW. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines. Molecular Cancer Research : McR. 6: 501-8. PMID 18337456 DOI: 10.1158/1541-7786.MCR-07-2075 |
0.393 |
|
2008 |
Taylor J, Hickson J, Lotan T, Yamada DS, Rinker-Schaeffer C. Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment Cancer and Metastasis Reviews. 27: 67-73. PMID 18049862 DOI: 10.1007/S10555-007-9106-7 |
0.78 |
|
2008 |
Szmulewitz RZ, Lotan T, Taylor J, Khan S, Nwani N, Rinker-Schaeffer C. ECTOPIC EXPRESSION OF MKK4/JNKK1 CONTROLS PROSTATE CANCER METASTATIC COLONIZATION BY CONTROLLING GROWTH OF DISSEMINATED CANCER CELLS AT SECONDARY SITES Journal of Urology. 179: 461-461. DOI: 10.1016/S0022-5347(08)61355-5 |
0.462 |
|
2006 |
Rinker-Schaeffer CW, Hickson JA. Stopping cancer before it colonizes Nature Medicine. 12: 887-888. PMID 16892031 DOI: 10.1038/Nm0806-887 |
0.756 |
|
2006 |
Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, Yamada SD. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma Cancer Research. 66: 2264-2270. PMID 16489030 DOI: 10.1158/0008-5472.Can-05-3676 |
0.813 |
|
2005 |
Vander Griend DJ, Kocherginsky M, Hickson JA, Stadler WM, Lin A, Rinker-Schaeffer CW. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7 Cancer Research. 65: 10984-10991. PMID 16322247 DOI: 10.1158/0008-5472.Can-05-2382 |
0.802 |
|
2005 |
Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker-Schaeffer CW. Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biology & Therapy. 4: 805-12. PMID 16082183 DOI: 10.4161/Cbt.4.8.1865 |
0.806 |
|
2004 |
Berger JC, Vander Griend D, Stadler WM, Rinker-Schaeffer C. Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cells. Anti-Cancer Drugs. 15: 559-68. PMID 15205597 DOI: 10.1097/01.Cad.0000132233.36512.Fa |
0.764 |
|
2004 |
Vander Griend DJ, Berger JC, Rinker-Schaeffer CW. Suppression of metastasis--a new function for known proteins. Journal of the National Cancer Institute. 96: 344-5. PMID 14996848 DOI: 10.1093/JNCI/DJH078 |
0.636 |
|
2004 |
Vander Griend DJ, Rinker-Schaeffer CW. A new look at an old problem: the survival and organ-specific growth of metastases. Science's Stke : Signal Transduction Knowledge Environment. 2004: pe3. PMID 14734785 DOI: 10.1126/stke.2162004pe3 |
0.692 |
|
2004 |
Jaeger EB, Chekmareva MA, Tennant TR, Luu HH, Hickson JA, Chen SL, Samant RS, Sokoloff MH, Rinker-Schaeffer CW. Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12 International Journal of Cancer. 108: 15-22. PMID 14618610 DOI: 10.1002/Ijc.11483 |
0.714 |
|
2003 |
Robinson VL, Hickson JA, Vander Griend DJ, Dubauskas Z, Rinker-Schaeffer CW. MKK4 and metastasis suppression: a marriage of signal transduction and metastasis research. Clinical & Experimental Metastasis. 20: 25-30. PMID 12650604 DOI: 10.1023/A:1022586318678 |
0.787 |
|
2003 |
Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. The Journal of Urology. 169: 1122-33. PMID 12576866 DOI: 10.1097/01.ju.0000051580.89109.4b |
0.43 |
|
2002 |
Yamada SD, Hickson JA, Hrobowski Y, Vander Griend DJ, Benson D, Montag A, Karrison T, Huo D, Rutgers J, Adams S, Rinker-Schaeffer CW. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma Cancer Research. 62: 6717-6723. PMID 12438272 |
0.818 |
|
2001 |
Jaeger EB, Samant RS, Rinker-Schaeffer CW. Metastasis suppression in prostate cancer. Cancer Metastasis Reviews. 20: 279-86. PMID 12085966 DOI: 10.1023/A:1015587411668 |
0.768 |
|
2001 |
Kim HL, Vander Griend DJ, Yang X, Benson DA, Dubauskas Z, Yoshida BA, Chekmareva MA, Ichikawa Y, Sokoloff MH, Zhan P, Karrison T, Lin A, Stadler WM, Ichikawa T, Rubin MA, ... Rinker-Schaeffer CW, et al. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. Cancer Research. 61: 2833-7. PMID 11306453 |
0.386 |
|
2000 |
Tennant TR, Rinker-Schaeffer CW, Stadler WM. Angiogenesis inhibitors. Current Oncology Reports. 2: 11-6. PMID 11122819 |
0.739 |
|
2000 |
Chien M, Rinker-Schaeffer C, Stadler WM. A G2/M growth arrest response to low-dose intermittent H2O2 in normal uroepithelial cells International Journal of Oncology. 17: 425-432. PMID 10938379 DOI: 10.3892/Ijo.17.3.425 |
0.325 |
|
2000 |
Tennant TR, Kim H, Sokoloff M, Rinker-Schaeffer CW. The Dunning model. The Prostate. 43: 295-302. PMID 10861749 DOI: 10.1002/1097-0045(20000601)43:4<295::Aid-Pros9>3.0.Co;2-W |
0.698 |
|
1999 |
Chien M, Astumian M, Liebowitz D, Rinker-Schaeffer C, Stadler WM. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer. Cancer Chemotherapy and Pharmacology. 44: 81-87. PMID 10367753 DOI: 10.1007/S002800050948 |
0.402 |
|
1998 |
Lucia MS, Bostwick DG, Bosland M, Cockett AT, Knapp DW, Leav I, Pollard M, Rinker-Schaeffer C, Shirai T, Watkins BA. Workgroup I: rodent models of prostate cancer. The Prostate. 36: 49-55. PMID 9650916 DOI: 10.1002/(Sici)1097-0045(19980615)36:1<49::Aid-Pros9>3.0.Co;2-6 |
0.373 |
|
Show low-probability matches. |